🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Study of Patient Preferences in Dialysis Treatment Choice: a Discrete Choice Experiment

Recruitingn/aAges 18 Years - anyAllUniversity Hospital, Caen
NCT07535320 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Background Compared to in-center dialysis, home dialysis is associated with better quality of life and lower healthcare system costs. However, barriers remain to its wider adoption. Chronic disease, particularly at an advanced stage, is a major driver of socioeconomic vulnerability. Among dialysis patients, the proportion of individuals covered by France's Universal Health Protection scheme (PUMA) is higher than in the general population. Similarly, those from the most disadvantaged social classes are overrepresented among dialysis patients compared to the overall French population. Dialysis can also lead to job loss. Financial compensation schemes may influence the choice of home dialysis. In France, patients who perform dialysis at home-either independently or with help from a trained family caregiver-are eligible for a "third-person compensatory allowance" (DTP). For some socioeconomi

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Adult patient * Patient with advanced chronic kidney disease receiving pre-surgery information (presentation of methods) * Patient enrolled in a social security program * Patient able to read and understand French * Patient able to complete the questionnaire (cognitive and sensory) Exclusion Criteria: * Minor patients * Patients transitioning from one method of extrarenal purification to another * Patients requiring urgent dialysis * Patients who cannot read or understand French * Patients under legal protection (guardianship, curatorship, judicial protection)
💊

What it tests

  • Questionnaire
📍

Where

2 sites
CHU de Caen
Caen, France
CHU
Caen, France
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy